The Office of Admissions recruits and matriculates those individuals most likely to enhance the overall health of our local, regional, national and international communities through the development of new knowledge and the provision of exemplary patient care. Each year, the School of Medicine matriculates a group of talented individuals who reflect the growing ethnic and cultural diversity of present day society, drawing on the knowledge and skills of individuals from all segments of society. Learn more about our Vision & Values.
Through innovative identification, recruitment and development programs, the School of Medicine has become recognized for the rich diversity of its student body. The Committee on Admissions has the daunting yet important job of selecting an outstanding entering freshman class each year from a bright, dedicated and diverse pool of applicants. The Committee will admit only those individuals who demonstrate the intellectual curiosity necessary for a lifetime of learning and who the Committee believes will maintain the highest standards of ethical and professional conduct.
Our students are our most prized asset and our dedicated faculty takes great joy and pride in helping each and every one of them develop into our future colleagues in the profession of medicine.
The University of Maryland, Baltimore is accredited by the Middle States Commission on Higher Education, 3624 Market St. Philadelphia, PA 19104
University of Maryland Strategic Partnership Unveils Center for Sports Medicine, Health and Human PerformanceThe University of Maryland in College Park and the University of Maryland, Baltimore (UMB) unveiled ambitious plans for the Center for Sports Medicine, Health and Human Performance. The new Center, a signature component of the Cole Field House project, will serve as a treatment facility for a wide spectrum of sports-related injuries, and will also serve as a research center for investigation into the treatment of sports related conditions, including the effects and consequences of traumatic brain injury.
The Zika Virus Threat and Vaccine Trial is the Focus of a Special Panel Discussion with Dean Reece and UMSOM Faculty ExpertsDean E. Albert Reece was joined by Center for Vaccine Development Director Dr. Kathleen Neuzil, and OB/GYN department chair Dr. Christopher Harman to discuss the threat of the Zika virus and the development of a new vaccine in a panel discussion hosted by Frontline Medical News.
Researchers Identify Novel Mechanism In Combination Drug Therapy For Acute Myeloid Leukemia, Other CancersResearchers have discovered a novel mechanism in a combination drug therapy that shows potential as a new approach for treating acute myeloid leukemia (AML) and many other cancers. When combined, these agents cause interactions that significantly disrupt cancer cells’ ability to survive DNA damage, according to a preclinical study published today in the journal Cancer Cell.
Led by investigators at the University of Maryland School Of Medicine, a national group of researchers has confirmed for the first time that two of the top genomic databases, which are in wide use today by clinical geneticists, reflect a measurable bias toward genetic data based on European ancestry over that of African ancestry. The results of their study were published today in the journal Nature Communication.
UM School of Medicine Launches Unprecedented Initiatives to Create New Generation of Research Scientists Among Students, Trainees and FacultyNew and expanded research development programs at the University of Maryland School of Medicine will include focus on developing junior, minority and female faculty investigators as well as students and trainees.